Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

2,361 public trials 354 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Completed

Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase

NCT00340834

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • North Central Neurology Associates, PC, 1809 Kress Street Cullman, Alabama, United States
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • The Neurology Center, 3907 Waring Road, Suite 3 Oceanside, California, United States
  • Associated Neurologists, PC, 69 Sand Pit Road, Suite 300 Danbury, Connecticut, United States
View all 170 locations
View Trial Details
Completed

Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis

NCT00333138

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Novartis Investigational site Montreal, Canada
  • Novartis Investigational site Ottawa, Canada
  • Novartis Investigational site Toronto, Canada
  • Novartis Investigational site Vancouver, Canada
View all 26 locations
View Trial Details
Completed

Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis

NCT00179478

Conditions
Acute Brainstem/Cerebellar Syndrome, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +25 more
Locations
  • MS Treatment Center at Griffin Hospital Derby, Connecticut, United States
  • Jaeb Center for Health Research Tampa, Florida, United States
  • MS Center of Atlanta Atlanta, Georgia, United States
  • Beta Research, Inc Elk Grove, Illinois, United States
View all 26 locations
View Trial Details
Completed

A Phase 4 Study to Assess the Impact of Patient Support Program on Health Related Quality of Life and Adherence in Subjects With Relapsing-Remitting Multiple Sclerosis Administered Rebif® With the RebiSmart™ Device

NCT01791244

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Please contact the Merck Communications Service for Recruiting locations Darmstadt, Germany
  • Research site Angered, Sweden
  • Research site Ängelholm, Sweden
  • Research Site Danderyd, Sweden
View all 14 locations
View Trial Details

Related conditions